Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-12-06
2009-12-29
Jiang, Dong (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S387900, C530S388100, C530S388150, C530S350000
Reexamination Certificate
active
07638603
ABSTRACT:
The present invention relates to a novel IL17RLP protein which is a member of the interleukin (IL)-17 receptor family. In particular, isolated nucleic acid molecules are provided encoding the human IL17RLP protein. IL17RLP polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of IL17RLP activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating, diagnosing, detecting, and/or preventing immune system-related disorders.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5869286 (1999-02-01), Yao et al.
patent: 6482923 (2002-11-01), Shi et al.
patent: 6635443 (2003-10-01), Shi et al.
patent: 6849719 (2005-02-01), Shi et al.
patent: 7094886 (2006-08-01), Shaughnessy
patent: WO 95/14772 (1995-06-01), None
patent: WO 96/29408 (1996-09-01), None
patent: WO 98/20165 (1998-05-01), None
patent: WO 98/58529 (1998-12-01), None
patent: WO 99/14240 (1999-03-01), None
patent: WO 99/35263 (1999-07-01), None
patent: WO 00/15959 (2000-03-01), None
patent: WO 00/55204 (2000-09-01), None
patent: WO 01/68848 (2001-09-01), None
Benjamin, L.E., et al., “A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF,”Development125:1591-1598, Company Of Biologists Limited (1987).
Bork, P., “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle,”Genome Res. 10:398-400, Cold Spring Harbor Laboratory Press (Apr. 2000).
Bork, P. and Bairoch, A., “Go hunting in sequence databases but watch out for the traps,”Trends Genet. 12: 425-427, Elsevier Trends Journals (Oct. 1996).
Brenner, S.E., “Errors in genome annotation,”Trends Genet9. 15:132-133, Elsevier Trends Journals (Apr. 1999).
Doerks, T., et al., “Protein annotation: detective work for function prediction,”Trends Genet. 14:248-250, Elsevier Trends Journals (Jun. 1998).
Ji, T.H. and Grossmann, M., “G protein-coupled receptors. I. Diversity of receptor-ligand interactions,”J Biol. Chem. 10:17299-17302, American Society for Biochemistry and Molecular Biology (1998).
Massagué, J., “The TGF-β family of growth and differentiation factors,”Cell49:437-438, Cell Press (1987).
Murdoch, C. and Finn, A., “Chemokine receptors and their role in inflammation and infectious diseases,”Blood95:3032-3043, American Society of Hematology (May 2000).
Parnet, P., et al., “IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP,”J. Biol. Chem. 271:3967-3970, American Society for Biochemistry and Molecular Biology (Feb. 1996).
Pilbeam, C.C., et al., “Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture,”Bone14:717-720, Elsevier Science (1993).
Skolnick, J., et al., “From genes to protein structure and function: novel applications of computational approaches in the genomic era,”Trends Biotechnol. 18:34-39, Elsevier Science Publishers (Jan. 2000).
Smith, T.F., et al., “The challenges of genome sequence annotations or ‘the devil is in the details,’”Nat. Biotech. 15:1222-1223, Nature America Publishing (Nov. 1997).
Vukicevic, S., et al., “Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7),”Proc. Natl. Acad. Sci. USA93:9021-9026, National Academy of Sciences (Aug. 1996).
Yao, Z., et al., “Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor,”Immunity3:811-821, Cell Press (Dec. 1995).
Pan et al., “Forced expression of murine IL-17E induces growth retardation, jaundice, a TH2-biased response and multiorgan inflammation in mice,”J. Immunol. 167: 6559-6567 The American Association of Immunologists (2001).
Kim et al., “Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production,”Blood100: 2330-2340 American Society of Hematology (Oct. 2002).
Lee et al., “IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1”,J. Biol. Chem. 276: 1660-1664 American Society for Biochemistry and Molecular Biology (Jan. 2001).
Moseley et al., “Interleukin-17 family and IL-17 receptors”Cytokine and Growth Factor Reviews14:155-174 Elsevier B.V. (2003).
Yokote et al., “Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis,”J. Biol. Chem. 271: 5101-5111 American Society for Biochemistry and Molecular Biology (Mar. 1996).
Stoltz et al., “The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells,”Proc. Natl. Acad. Sci. USA93:2832-2837, National Academy of Sciences (Apr. 1996).
Tian et al., “Evi27 encodes a novel membrane protein with homology to the IL17 receptor”Oncogene19: 2098-2109 Nature Publishing Group (2000).
Maezawa et al., “Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling,”J. Immunol. 176: 1013-1018 The American Association of Immunologists (Jan. 2006).
Shi et al., “A novel cytokine receptor-ligand pair: Identification, molecular characterization and in vivo immunomodulatory activty”J. Biol. Chem.275:19167-19176 American Society for Biochemistry and Molecular Biology (Jun. 2000).
Spriggs, Melanie K., “Interleukin-17 and its receptor.”J.Clin.Immunology17: 366-369 Springer (Sep. 1997).
Ruben Steven M.
Shi Yanggu
Human Genome Sciences Inc.
Jiang Dong
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Antibodies against interleukin 17 receptor-like protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against interleukin 17 receptor-like protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against interleukin 17 receptor-like protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073000